The largest DRAM memory manufacturers have come under legal pressure in the United States. Samsung Electronics, SK Hynix, and Micron Technology have been sued in a federal court in California by a group of consumers and small businesses alleging price-fixing and artificial supression of memory supply. The case could become one of the more important tests for the market at a time of extreme valuations and shortages.
According to the lawsuit, the manufacturers allegedly coordinated restrictions on the supply of traditional DRAM modules, including DDR3 and DDR4, while at the same time redirecting a larger share of production capacity toward HBM. The plaintiffs claim these actions led to market shortages and a sharp rise in memory component prices.
Samsung, SK Hynix, and Micron control the vast majority of the global DRAM supply. This means that any coordinated production cuts would have a much greater impact on the market than similar actions in less specialized industries.
In recent weeks, makers of electronics, consoles, and computer hardware have increasingly pointed to higher component costs as a reason for price increases. For consumers, the problem is therefore not limited to the PC parts market, but also affects computers, consoles, smartphones, and other devices that use DRAM.
At this stage, however, these are still only allegations. The case will require proving that the observed supply constraints were not solely the result of a rational response by manufacturers to the AI boom, but stemmed from coordinated conduct that restricted competition.
Potentially most significant is the fact that RAM makers, including Samsung and SK Hynix, which are named now, were once already found guilty of exactly this kind of behavior in the 1998–2002 period. On the other hand, a nearly identical lawsuit reached court in 2018, in which Samsung, Hynix, and Micron were again accused of price-fixing, but the court then deemed the evidence insufficient.
At the same time, Samsung and SK Hynix are announcing massive investment plans in South Korea, putting considerable pressure on valuations of companies in the sector, which are currently supported by expectations of prolonged shortages.
As part of a government program to expand the semiconductor ecosystem, both companies are to build new fabs, with the total scale of the project counted in the hundreds of billions of dollars.
Any margin pressure from additional supply, if it materializes, will be significantly delayed, however, because building and bringing advanced manufacturing capacity online takes years.
MU.US (D1)
The company’s uptrend is very strong and steep, but the FIBO level helps identify potential resistance and support zones. If, for some reason, supply were to take the initiative, strong resistance would most likely be the (also psychological) $1,000 level. For buyers, the next target is a broad resistance zone around $1,300. Source: xStation5
⬆️US100 rises 1.6% at end of Q2
US OPEN: Nasdaq seals best quarter in years
Daily summary: Semiconductors are swallowing Wall Street
IBM shows a breakthrough: Leader of the next revolution?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.